Challenger Rejects Takeover Offer, Seeks Better Proposal
Challenger’s board says TAL Daiichi Life Australia’s indicative offer for the shares it does not already own is too low to recommend to shareholders. The board intends to engage with TAL Daiichi Life Australia on whether a recommendable proposal can be reached, but says there is no certainty of a binding offer or transaction.
Closing price · 2026-10-26: $11.85 · -0.59%